Cargando…
Under-Reported Aspects of Platinum Drug Pharmacology
Platinum drugs remain the backbone of many antineoplastic regimens. Among the numerous chemical or pharmacological effects of platinum drugs, some aspects tend to be under-reported. Thus, this perspective paper intends to stress some neglected properties of platinum drugs: first, the physico-chemica...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155231/ https://www.ncbi.nlm.nih.gov/pubmed/29760371 http://dx.doi.org/10.3390/molecules22030382 |
_version_ | 1783357855314739200 |
---|---|
author | Theile, Dirk |
author_facet | Theile, Dirk |
author_sort | Theile, Dirk |
collection | PubMed |
description | Platinum drugs remain the backbone of many antineoplastic regimens. Among the numerous chemical or pharmacological effects of platinum drugs, some aspects tend to be under-reported. Thus, this perspective paper intends to stress some neglected properties of platinum drugs: first, the physico-chemical characteristics (aquation reaction kinetics) that determine site-specific toxicity; second, the impact on RNA molecules. Knowledge of the ‘RNA world’ has dramatically changed our understanding of cellular and molecular biology. The inherent RNA-crosslinking properties should make platinum-based drugs interact with coding and non-coding RNAs. Third, we will discuss the impact on the immune system, which is now recognized to substantially contribute to chemotherapy efficacy. Together, platinum drugs are in fact old drugs, but are worth re-focusing on. Many aspects are still mysterious but can pave the way to new drugs or an improved application of the already existing compounds. |
format | Online Article Text |
id | pubmed-6155231 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61552312018-11-13 Under-Reported Aspects of Platinum Drug Pharmacology Theile, Dirk Molecules Perspective Platinum drugs remain the backbone of many antineoplastic regimens. Among the numerous chemical or pharmacological effects of platinum drugs, some aspects tend to be under-reported. Thus, this perspective paper intends to stress some neglected properties of platinum drugs: first, the physico-chemical characteristics (aquation reaction kinetics) that determine site-specific toxicity; second, the impact on RNA molecules. Knowledge of the ‘RNA world’ has dramatically changed our understanding of cellular and molecular biology. The inherent RNA-crosslinking properties should make platinum-based drugs interact with coding and non-coding RNAs. Third, we will discuss the impact on the immune system, which is now recognized to substantially contribute to chemotherapy efficacy. Together, platinum drugs are in fact old drugs, but are worth re-focusing on. Many aspects are still mysterious but can pave the way to new drugs or an improved application of the already existing compounds. MDPI 2017-02-28 /pmc/articles/PMC6155231/ /pubmed/29760371 http://dx.doi.org/10.3390/molecules22030382 Text en © 2017 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Perspective Theile, Dirk Under-Reported Aspects of Platinum Drug Pharmacology |
title | Under-Reported Aspects of Platinum Drug Pharmacology |
title_full | Under-Reported Aspects of Platinum Drug Pharmacology |
title_fullStr | Under-Reported Aspects of Platinum Drug Pharmacology |
title_full_unstemmed | Under-Reported Aspects of Platinum Drug Pharmacology |
title_short | Under-Reported Aspects of Platinum Drug Pharmacology |
title_sort | under-reported aspects of platinum drug pharmacology |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155231/ https://www.ncbi.nlm.nih.gov/pubmed/29760371 http://dx.doi.org/10.3390/molecules22030382 |
work_keys_str_mv | AT theiledirk underreportedaspectsofplatinumdrugpharmacology |